Skip to content

DECLEVE

Dissolved and wound up on 30-09-2019 KBO/BCE: BE 0426.458.025 subsidiary of PHARMA HOLD SA

Mandates through the years

4 names
Anne-Catherine BAUS
Managing director
Michel DESTREBECQ
Managing director
PHARMA HOLD
Managing director
Earliermandate already running before its first mention
Mandates as a list
  • Anne-Catherine BAUS
    • Managing director, until 27-12-2019
  • Annie DECLEVE
    • Director, appointed by deed of 26-06-2017, until 27-12-2019
  • Michel DESTREBECQ
    • Managing director, until 27-12-2019
  • PHARMA HOLD
    • Managing director, until 27-12-2019

Control

Consolidating parent
Equity €142,224
Loss €223 in 2025 (loss €6,895 in 2024)
Checked score 92
consolidates
This company
DECLEVE
Equity €20,515
Loss €21,188 in 2018

Capital

Capital
€75,000
Source
2018 annual accounts

Owners through the years

as the annual accounts name them
consolidates
Owners as a list

Source: parent in its own accounts, lists of holdings in the owners' accounts

Office holders in the KBO →

Next steps